Journal Logo

Poster Session I: Myeloma and other monoclonal gammopathies – Clinical

PF626 HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES OF ORAL IXAZOMIB MAINTENANCE THERAPY POST AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) FROM TOURMALINE-MM3

Schjesvold, F.1,2; Goldschmidt, H.3; Maisnar, V.4; Spicka, I.5; Abildgaard, N.6; Rowlings, P.7; Odom, D.8; Gnanasakthy, A.9; Suryanarayan, K.10; Cain, L.11; Romanus, D.11; Rajkumar, S.V.12; Dimopoulos, M.A.13

Author Information
doi: 10.1097/01.HS9.0000560788.86257.a3
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.